BSPSX | VFFSX | BSPSX / VFFSX | |
Total Expense Ratio | 0.22 | 0.01 | 2,200% |
Annual Report Gross Expense Ratio | 0.22 | 0.01 | 2,200% |
Fund Existence | 12 years | 9 years | - |
Gain YTD | 7.338 | 6.811 | 108% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000 | 5000000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 50.1B | 1.43T | 4% |
Annual Yield % from dividends | 1.03 | 1.23 | 84% |
Returns for 1 year | 14.52 | 13.52 | 107% |
Returns for 3 years | 69.63 | 64.43 | 108% |
Returns for 5 years | 111.40 | 100.98 | 110% |
Returns for 10 years | 234.75 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
RSEE | 30.67 | 0.25 | +0.83% |
Rareview Systematic Equity ETF | |||
RSP | 185.18 | 0.89 | +0.48% |
Invesco S&P 500® Equal Weight ETF | |||
PBE | 65.66 | 0.23 | +0.36% |
Invesco Biotechnology & Genome ETF | |||
IBHF | 23.14 | 0.02 | +0.09% |
iShares iBonds 2026 Term HY & Inc ETF | |||
SKRE | 10.48 | -0.22 | -2.06% |
Tuttle Cptl Dl 2X Invrs Rgnl Banks ETF |